AtkinsRéalis books Pickering contract: 15 analysts rate AtkinsRéalis stock Buy

Published on 10/05/2026 at 08:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 10.00 percent to CAD 3.0 billion in the second quarter. AtkinsRéalis stock costs EUR 54.12 on October 5, 2026 after EUR 54.16.

ATRL, CA04764T1049, Illustration mit AI erstellt.

AtkinsRéalis (CA04764T1049) was trading at EUR 54.12 at Lang & Schwarz on October 5, 2026 at 8:39 a.m. CEST, minus 0.07 percent versus the prior close of EUR 54.16. The company has added a major Pickering nuclear contract to its project pipeline, while 15 analysts carry a Buy consensus for AtkinsRéalis stock.

Pickering contract expands nuclear pipeline

According to AtkinsRéalis on September 21, 2026, a joint venture with Aecon signed a three-year contract worth CAD 1.7 billion with Ontario Power Generation for work on Unit 5 of the Pickering CANDU nuclear station. AtkinsRéalis will add its share to its Nuclear backlog in the third quarter of 2026, while similar work on Units 6, 7 and 8 remains subject to regulatory approval.

The contract gives the nuclear segment a long-duration project with engineering, design, delivery, and program-management work. The release also states that the project is intended to support Unit 5 operations into the 2060s, linking the order to the company’s broader nuclear expansion strategy.

Second-quarter growth supports outlook

AtkinsRéalis reported CAD 3.0 billion of revenue in the second quarter of 2026, up 10.00 percent from the second quarter of 2025. Adjusted EBITDA increased 14.20 percent to CAD 292.9 million, while adjusted diluted earnings per share rose 19.80 percent to CAD 0.97.

The same report put backlog at CAD 20.2 billion as of June 30, 2026. AtkinsRéalis also raised its full-year 2026 Nuclear revenue outlook from CAD 2.5 billion to CAD 2.7 billion, giving the Pickering project a clear strategic setting.

Analyst target remains above market price

According to MarketScreener on September 15, 2026, the mean analyst consensus was Buy from 15 analysts, with an average target of CAD 115.40. The target was CAD 28.99 above the finance quote of CAD 86.41 on October 2, 2026, a 25.12 percent gap below the target.

AtkinsRéalis stock trades in pre-market

AtkinsRéalis stock was trading at EUR 54.12 at Lang & Schwarz on October 5, 2026 at 8:39 a.m. CEST, minus 0.07 percent versus the Lang & Schwarz prior close of EUR 54.16 on October 2, 2026. The TSX-listed stock had a market capitalization of CAD 14.0 billion on October 2, 2026.